收费类受体7/8对手 促进交叉蛋白-10介导的抗炎疗法
Grahmm A Funk1, Jin Xie1, Tamara A Kucaba2
1Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047, United States.
ACS pharmacology & translational science
|January 15, 2026
概括
一种新的托尔类受体 (TLR) 7/8对抗剂,621,通过促进抗炎细胞因子和免疫抑制细胞,有效抑制炎症. 这种化合物显示出作为一种新的治疗炎症性疾病的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 收费类受体 (TLR) 7和8是关键的模式识别受体,参与对病原体的免疫反应.
- 激动剂对TLR7/8的激活促进炎症,而它们的对抗作用在很大程度上仍未被探索.
研究的目的:
- 为了研究一种新型TLR7/8抗剂的免疫抑制潜力,指定621.1.
- 阐明TLR7/8对抗作用的免疫机制.
主要方法:
- 使用小鼠树突细胞 (DC) 试验的体外研究.
- 在小鼠模型中的体内研究,包括全身管理和DSS-结肠炎模型.
- 使用TLR7/8激动剂 (558) 和使用TLR4激动剂 (LPS) 或Resiquimod (RESQ) 的挑战进行比较分析.
主要成果:
- 621在DC中诱导了抗炎IL-10的产生,而没有促进促炎性TNF.
- 在小鼠中,系统性621的使用增加了血清IL-10和降低了TNF.
- 621治疗增加了调节性T细胞 (Tregs) 和M2巨细胞,并减轻了DSS-结肠炎.
结论:
- 新型TLR7/8对手621表现出显著的抗炎和免疫抑制特性.
- 621促进向抗炎性免疫表型的转变.
- 这种化合物代表了潜在的新型治疗剂,用于炎症性疾病.
相关概念视频
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Inflammatory Response
16.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.0K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
490
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
490
The JAK-STAT Signaling Pathway
12.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.0K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K


